Best-in-class risk solutions for the US health reinsurance market.
HMO
Reinsurance
Excess of loss reinsurance offered to regional health plans and health maintenance organizations throughout the United States and US Territories. Target market includes commercial, Medicare and Medicaid regional health plans as well as large national organizations operating regional plans in multiple states. Coverage includes Continuation of Coverage in the event of plan insolvency when required by state regulation.
Provider
Excess Loss
Excess of loss insurance offered to health care providers such as hospitals, hospital systems, physician groups, accountable care organizations and other health care providers who have assumed medical risk by entering into risk-bearing contracts with HMOs, health plans, managed care organizations, insurers, state Medicaid programs, CMS for Medicare programs or self-funded employer groups.
Medical
Reinsurance
Excess of loss reinsurance offered to regional health insurance companies, captive insurance companies and risk retention groups throughout the United States, US Territories and Cayman. Covered underlying products can include, but are not limited to, first dollar medical (commercial or Medicare), Employer Stop Loss, Exchange, limited benefit, short-term medical and organ transplant. Coverage is available on a period certain or risks attaching basis.
Employer
Stop Loss
Specific and Aggregate excess of loss insurance coverage offered to large self-funded employers. Sequoia’s target market is focused on "specialty" ESL offered through health plans/HMOs with tighter networks and meaningful medical, cost and catastrophic claim management. Target market also includes employer direct contracting arrangements, employer’s utilizing captive strategies and stop loss of large hospital systems focused on managing care within a well-defined network. Traditional ESL will only be considered through our Managed Care distribution sources.
Client Captive
Programs
Risk Participation programs utilizing client captive insurance companies. Services include client risk sharing evaluation/structure, pricing and ceded reinsurance claim administration.
Cell &
Gene Therapy
With the emergence of novel cell and gene therapies poised to revolutionize treatment for a growing number of disease states, Sequoia recognizes the need for innovative financing and risk mitigation solutions to manage the financial exposure and volatility these therapies pose. Sequoia provides customized financial risk transfer protection coupled with expert, comprehensive, multidisciplinary, end to end cost mitigation solutions for our clients.